Fresenius | FRE - Interest Expense On Debt


Fresenius reported EUR81M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 54M 3M Dec/2025
AstraZeneca USD 484M 181M Dec/2025
BASF EUR 236M 15M Dec/2025
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 7.5M 19.5M Jun/2025
DaVita Healthcare Partners USD 148.25M 17.41B Dec/2025
Demant DKK 398M 37M Dec/2025
E.ON EUR 543M 7M Dec/2025
Essilor EUR 147M 102.5M Jun/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 85M 8.1M Dec/2025
Getinge SEK 164M 1000K Dec/2025
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GN Store Nord DKK 296M 42M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 121M 5M Dec/2025
Novartis USD 304M 23M Dec/2025
Philips EUR 109M 31M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
RWE EUR 138M 214M Dec/2025
Sanofi EUR -25M 252M Dec/2025
Smith & Nephew USD 69M 1000K Dec/2025